Pharmaceutical Technology E-Alert:
Having trouble viewing this e-mail? Click here.
  Pharmaceutical Technology Europe E-Alert
 
27 April 2012

IN THIS ISSUE
Merck cuts
GSK divests
FDA postmarketing
Vaccine prize
Twitter

Merck Group Announces Job Cuts
The Merck Group has revealed further details about its previously announced restructuring programme, including plans to eliminate approximately 580 jobs. More...
 
GSK Divests OTC Brands Worth $264.7 Million
GlaxoSmithKline has reached an agreement to divest certain over-the-counter brands in select territories to South Africa’s Aspen Pharmacare Holdings for approximately $264.7 million. More...
 
FDA Reports Improvement in Postmarket Drug Oversight
The FDA has detailed the agency’s objective to give postmarket drug-safety monitoring the same priority as premarket drug review. More...
 
EC Offers Cash Prize for Vaccine Stability
The European Commission is offering a €2-million inducement prize to encourage innovation in the area of cold-chain logistics and vaccine stability. More...
 
All atweet!
Keep up to date with the latest news, gossip and rumours hitting the web about the pharmaceutical industry by following us on Twitter. More...
Key Topics:

Latest blog posts
Pharma's Efforts in Developing Countries
Live from ExcipientFest: Deadly Sins of Quality Management
GlaxoSmithKline: A Rebuffed Suitor for the Moment
More blog posts

Latest manufacturing articles
Achieving Containment in High-Potency Manufacturing
Freeze-Drying: Is Technology Advancing Fast Enough?
Manufacturers Wrestle with Drug Abuse and Shortages
More articles

Upcoming events
INTERPHEX 2012 (1–3 May | USA)
CPhI South East Asia (10–12 May | Indonesia)
Pharmaceutical Compliance Congress (14–16 May | Hungary)
More events
Product/Service Profile
Shimadzu

The Nexera MP UHPLC for LC/MS analysis in drug detection processes
Shimadzu has introduced the Nexera MP UHPLC as a Front End system for LC/MS. The Nexera MP is perfect for LC/MS analysis conducted in pharmacokinetics and synthesis stages in drug detection processes.
Read more


Up & Coming Webcasts

Scale up and Manufacturing Challenges of Controlled Release Parenteral Drugs
Tuesday, May 15, 2012 at 11:00 a.m. - 12:00 p.m. EST.
Learn how controlled release parenteral products are developed and successfully commercialized using biodegradable polyester based polymers. Critical processing parameters and quality attributes as related to controlled release parenteral products will be discussed
Sponsored by: Evonik Industries
Read More...


 
Survey
What would you identify as the most significant advance in analytical instrumentation and methods development during the past 5-10 years?
 
Increased use of hyphenated methods 19%
 
 
Adaption of process analytical technology (PAT) for in-line, at-line, and on-line testing 30%
     
 
Greater throughput in chromatographic methods (i.e. UPLC, fast HPLC) 30%
     
 
Improvement in instrumentation and method for detecting trace impurities 21%

This week we would like to know...

What do you think is the biggest hurdle when it comes to effective quality management?

Click here to vote

Contact Us
Click here to contact editorial.

Click here to contact sales.